StemCells (STEM)
StemCells Revenues: 0.541M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
STEM Revenues Rankings
| Overall | 1st percentile | 4348 of 4431 |
| Sector | 8th percentile | 431 of 471 in Healthcare |
| Industry | 15th percentile | 111 of 132 in Biotechnology |
STEM Revenues Range, Past 5 Years
| Minimum | 0.012M | Sep 2008 |
| Maximum | 7.84M | Jun 2007 |
| Average | 0.6127M |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these STEM related companies
STEM News
StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial
May 17, 9:03AM Benzinga
May 17, 9:03AM Benzinga
StemCells, Inc. Reports First Quarter 2012 Financial Results and Provides Business Update
May 10, 4:02PM GlobeNewswire
May 10, 4:02PM GlobeNewswire
StemCells, Inc. Announces Webcast to Discuss First Quarter 2012 Financial Results and Business Update
May 07, 9:00AM GlobeNewswire
May 07, 9:00AM GlobeNewswire
@missyaubaby Do you think $STEM will go back up pass $1.11 or will it sink more
about 59 days ago by masu3701
about 59 days ago by masu3701
StemCells (STEM) Reports Encouraging Data for HuCNS-SC in PMD Patients
Apr 02, 6:48AM Street Insider
Apr 02, 6:48AM Street Insider
StemCells, Inc. Announces Webcast to Discuss Pelizaeus-Merzbacher Disease Clinical Trial Results
Mar 30, 2:15PM GlobeNewswire
Mar 30, 2:15PM GlobeNewswire
StemCells, Inc. Grants genOway Exclusive License to Gene Insertion Technology for Genetically Engineered Mice
Mar 20, 9:00AM GlobeNewswire
Mar 20, 9:00AM GlobeNewswire
StemCells, Inc. Reports Fourth Quarter and Year End 2011 Financial Results and Provides Business Update
Mar 13, 4:05PM GlobeNewswire
Mar 13, 4:05PM GlobeNewswire
StemCells, Inc. Announces Webcast to Discuss 2011 Financial Results and Business Update
Mar 09, 9:00AM GlobeNewswire
Mar 09, 9:00AM GlobeNewswire
StemCells, Inc. to Present at the 24th Annual Roth Growth OC Conference
Mar 08, 9:00AM GlobeNewswire
Mar 08, 9:00AM GlobeNewswire
StemCells, Inc. to Participate in Qatar International Conference on Stem Cell Science and Policy 2012
Feb 27, 9:00AM GlobeNewswire
Feb 27, 9:00AM GlobeNewswire
RT @highgrowthfinancial $STEM called this yesterday. hope u got in>did you listen to their live WEB presentation today at 11:00?
about 108 days ago by earthdogpj
about 108 days ago by earthdogpj
$STEM http://stks.co/2OYO low priced from watch list now over 50-day EMA big volume
about 108 days ago by StockTiger
about 108 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/2OR5 including: $ORLY $INCY $STEM $HLS $ELGX $CAM $CZZ
about 108 days ago by StockTiger
about 108 days ago by StockTiger
Market Wrap Video + Additions to Watch List http://stks.co/2NyU including: $ORLY $INCY $STEM $HLS $ELGX $CAM $CZZ
about 108 days ago by StockTiger
about 108 days ago by StockTiger
look 4 $STEM to gain more tomarrow. been consolidating here since last FDA update
about 109 days ago by highgrowthfinancial
about 109 days ago by highgrowthfinancial
FDA Grants StemCells (STEM) Authorization for Age-Related Macular Degeneration Clinical Trial
Feb 02, 9:06AM Street Insider
Feb 02, 9:06AM Street Insider
StemCells Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
Feb 02, 9:01AM Benzinga
Feb 02, 9:01AM Benzinga
StemCells, Inc. Receives FDA Authorization for Age-Related Macular Degeneration Clinical Trial
Feb 02, 9:00AM GlobeNewswire
Feb 02, 9:00AM GlobeNewswire
StemCells, Inc. Announces Publication of Preclinical Data Demonstrating Its Human Neural Stem Cells Preserve Vision
Jan 30, 9:00AM GlobeNewswire
Jan 30, 9:00AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| STEM | 0.69 | -0.02 | -2.82% | 16.54M |
| STEC | 6.96 | -0.10 | -1.42% | 325.75M |
| STE | 29.24 | -0.62 | -2.08% | 1.721B |
| STD | 5.33 | +0.01 | +0.19% | 47.40B |
| ZZ | 1.68 | +0.05 | +3.07% | 169.55M |
| ZX | 3.05 | -0.02 | -0.65% | 157.41M |
| ZUMZ | 35.71 | -1.08 | -2.94% | 1.151B |
| ZTR | 3.03 | +0.00 | +0.00% | |
| ZSTN | 2.21 | +0.00 | +0.00% | 25.64M |
| ZSL | 65.62 | -3.34 | -4.84% |